| |
TTD
Drug ID:
DAP001212
| Drug
Information |
| Name | Norethindrone | | Synonyms | norethindrone; HMS501L15; N.E.E; 17-Ethynyl-17-hydroxyestr-4-en-3-one; Norethindirone; Noriday; BSPBio_000066; Noretisterona; BRD-A39415247-001-02-1; Micronor; Triella; EINECS 200-681-6; Utovlan; Norethin 1/35 E; Norpregneninolone; Minovlar; Normapause; Norethin; 17alpha-Ethynyl-4-estren-17-ol-3-one; Nodiol; ARONIS24281; MLS001163874; Norfor; Norlutin; Synphase; 46525_RIEDEL; LMST02030097; Microneth; STOCK1N-04274; Gestest; Noraethisteronum; Synphasic 28; Norethisteron; Jenest; Ortho-Novum 1 35; HSDB 3370; Norethindrone (USP); SC 4640; Prestwick_646; SMR000499579; Micronor (TN); N.E.E.; CPD000499579; SMR000718762; C05028; Oprea1_606355; 19-Nor-17alpha-ethynyltestosterone; Ovysmen 0.5 35; Orlest; Norethisterone [Progestins]; Gencept; Nor-Q.D; Ethynylmortestosterone; Primolut-N; Ciclovulan; CID5702093; CID4536; HMS2090D21; 19-Norethisterone; 4-Estren-17alpha-ethynyl-17beta-ol-3-one; STK730956; Nelova; Norgestin; 17-Ethinyl-19-nortestosterone; Nora-BE; Noretisterona [INN-Spanish]; Conceplan; SPBio_001052; Noriday 28; D00182; Brevicon; KBio2_001491; 19-Norethindrone; 19-Nor-17alpa-ethynyltestosterone; MolPort-003-861-444; KBio2_006627; BB_NC-0600; Brevinor 28; Spectrum3_000521; AC1Q6OG5; Norethynodron; Prestwick3_000253; BPBio1_000074; KBio2_004059; Norethynodrone; Brevinor; N0449; 17-alpha-Ethynyl-19-nortestosterone; AC1O5EOU; Estrinor; 17-ethynyl-17beta-hydroxyestr-4-en-3-one; Micronovum; Ortho 1 35; Norluten; HMS1920B10; AR-1C1071; AI3-26422; Anovule; BRD-K92073408-001-03-3; Prestwick2_000253; Nor-Q.D.; Norcept; Ortho-Novum 7 7 7; BRN 1915671; 19-Norethinyltestosterone; 17.alpha.-Ethynyl-4-estren-17-ol-3-one; Noretisterone; Proluteasi; Errin; HMS2091J10; Conludag; Ethinyl-19-nortestosterone; Ethynylnortestosterone; Norethindrone [USAN]; Ortho 7 7 7; UNII-T18F433X4S; Genora; WLN: L E5 B666 OV MUTJ E FQ F1UU1 -A&F; Demulen; Noresthisterone; Norethisteronum; Ortho-Novum 1 50; Norpregneninotone; Norethyndron; AC1L1M2R; 17.alpha.-Ethinyl-19-nortestosterone; Norethadrone; Brevinor 21; BSPBio_002101; KBio1_000553; 17alpha-Ethynyl-19-nortestosterone; NSC9564; Norcept-E; CCRIS 484; Conludaf; MLS001304093; 19-Nortestosterone, 17-ethynyl-; N4128_SIGMA; Mini-pill; Utovlar; MolPort-002-507-131; Norethisteronum [INN-Latin]; A3564/0151191; CHEBI:7627; Loestrin; Norcolute; Norcolut; Spectrum2_001066; Primolut-N (TN); Norluton; NCGC00178820-01; 19-Nor-17-ethinyl testosterone; Norethin 1/50 M; 17alpha-Ethinyl-19-nortestosterone; IDI1_000553; MolPort-002-509-542; Spectrum4_000079; Trinovum 21; AKOS004119895; 19-Nor-17-ethinyltestosterone; component of Noriday; Activella; Noretisterone [DCIT]; SPBio_002285; Spectrum_001011; 17.alpha.-Ethynyl-19-nortestosterone; Camila; DB00717; AC1L1IDS; 19-Nor-17.alpha.-ethynyltestosterone; Menzol; AC1NWAOX; 19-Nor-ethinyl--4,5-testosterone; NSC-9564; Anovulatorio; 17-alpha-Ethynyl-4-estren-17-ol-3-one; MolPort-002-728-977; Jenest-28; Nor-QD; 46525_FLUKA; SPECTRUM1500437; 19-Nor-17-alpha-ethynyltestosterone; Primolut N; CID6432649; Prestwick1_000253; MLS001076679; Noralutin; Camila (TN); ST094767; Mini-Pe; AC-11100; CID6230; Brevinor-1 28; Norethisterone; CHEMBL1162; SAM002564223; ZINC03814419; Spectrum5_001198; 19-Nor-ethindrone; Norethisterone (JP15); Tri-Norinyl; Ovysmen 1 35; KBio3_001601; Norethindrone Norethisterone; Prestwick0_000253; KBioGR_000637; Milli; Micronett; DivK1c_000553; I06-0104; 68-22-4; KBioSS_001491; Brevinor-1 21; NCGC00179669-01; HMS1568D08; Norpregneninlone; Anhydrohydroxynorprogesterone; LS-97425; Ethinylnortestosterone; NINDS_000553 | | Indication | Oral contraceptive | Approved [1] | | Structure |
Click to save drug structure in 3D MOL format
Click to save drug structure in 2D MOL format | | Therapeutic Class | Contraceptive Agents | | CAS Number | CAS 68-22-4 | | Formular | C20H26O2 | | PubChem Compound ID | CID 4536. | | PubChem Substance ID | SID 75017. | | ChEBI | 7627; | | SuperDrug ATC ID | G03AC01; | | SuperDrug CAS ID | 000068224; | | Target | Progesterone receptor |  | Agonist | [2] | | Ref 1 | Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77. Epub 2007 Feb 20. To Reference | | Ref 2 | Progesterone receptor ligand binding pocket flexibility: crystal structures of the norethindrone and mometasone furoate complexes. J Med Chem. 2004 Jun 17;47(13):3381-7. To Reference |
Welcome
to sign our Guestbook.
If you
find any error in data or bug in web service, please kindly report it
to Dr.
Zhu.
Dr.
Chen Yuzong
Deputy Director of Center
for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore
All rights reserved.
|
|